Baylor Scott & White Research Institute is a clinical research site located in Dallas, Texas, United States 75246.
Crixeo Health Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.
Baylor Scott & White Research Institute has participated in 55 clinical trials with 38 currently active.
Therapeutic areas: Hepatitis B, Contrast Induced Acute Kidney Injury, Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia.
Sponsors: Baylor Research Institute, Aptabio Therapeutics, Inc., Autolus Limited.
Trust Score: 86/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Baylor Scott & White Research Institute has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Baylor Scott & White Research Institute has 55 clinical trials on record, with 38 currently active. Their work covers Hepatitis B, Contrast Induced Acute Kidney Injury, Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia.
Yes — Baylor Scott & White Research Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.